A detailed history of Pivotal Bio Venture Partners Investment Advisor LLC transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Pivotal Bio Venture Partners Investment Advisor LLC holds 4,494,851 shares of INZY stock, worth $13.5 Million. This represents 18.53% of its overall portfolio holdings.

Number of Shares
4,494,851
Previous 4,494,851 -0.0%
Holding current value
$13.5 Million
Previous $20 Million 17.26%
% of portfolio
18.53%
Previous 18.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$4.09 - $7.0 $3.41 Million - $5.83 Million
833,333 Added 22.76%
4,494,851 $18.9 Million
Q2 2023

Aug 11, 2023

BUY
$4.93 - $6.74 $2.21 Million - $3.02 Million
447,932 Added 13.94%
3,661,518 $20.4 Million
Q1 2023

May 12, 2023

BUY
$1.3 - $5.73 $718,161 - $3.17 Million
552,432 Added 20.76%
3,213,586 $18.4 Million
Q2 2022

Aug 12, 2022

BUY
$3.2 - $5.96 $3.42 Million - $6.38 Million
1,070,000 Added 67.25%
2,661,154 $12.7 Million
Q4 2020

Feb 09, 2021

BUY
$19.95 - $27.55 $31.7 Million - $43.8 Million
1,591,154 New
1,591,154 $32.8 Million

Others Institutions Holding INZY

About Inozyme Pharma, Inc.


  • Ticker INZY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,145,700
  • Market Cap $121M
  • Description
  • Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...
More about INZY
Track This Portfolio

Track Pivotal Bio Venture Partners Investment Advisor LLC Portfolio

Follow Pivotal Bio Venture Partners Investment Advisor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pivotal Bio Venture Partners Investment Advisor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pivotal Bio Venture Partners Investment Advisor LLC with notifications on news.